2017
DOI: 10.1016/j.rbr.2017.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Recomendações da Sociedade Brasileira de Reumatologia para diagnóstico e tratamento da febre chikungunya. Parte 2 – Tratamento

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
13

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(24 citation statements)
references
References 37 publications
0
11
0
13
Order By: Relevance
“…In its recommendations for the treatment of CHIK, the BSR suggests the administration of methotrexate in the chronic phase of the disease or (considering withdrawal difficulty from this corticosteroid) the administration of a nonsteroidal antiinflammatory drug for the treatment of musculoskeletal pain refractory to analgesics 20 . In the present study, majority of the patients were not taking any medication despite experiencing pain, which may be related to the lack of medical follow-up with a skilled professional for the treatment of this illness.…”
Section: Discussionmentioning
confidence: 99%
“…In its recommendations for the treatment of CHIK, the BSR suggests the administration of methotrexate in the chronic phase of the disease or (considering withdrawal difficulty from this corticosteroid) the administration of a nonsteroidal antiinflammatory drug for the treatment of musculoskeletal pain refractory to analgesics 20 . In the present study, majority of the patients were not taking any medication despite experiencing pain, which may be related to the lack of medical follow-up with a skilled professional for the treatment of this illness.…”
Section: Discussionmentioning
confidence: 99%
“…The Brazilian Ministry of Health's recommendations were not used because, in addition to the maximum dose being very high (40 mg), the study carried out by the Brazilian Society of Rheumatology did not show benefits in doses above 20 mg. The Ministry of Health places a maximum treatment time of 21 days with a gradual dose reduction, disregarding the reduction of symptoms, clinical improvement, and options in case of a therapeutic failure within the specified time [4].…”
Section: Discussionmentioning
confidence: 99%
“…In cases of pain resurgence during corticosteroid reduction, a 2.5 mg reduction was performed every 7 days. For patients who had more than 3 months of symptoms (chronic), what is recommended by the Brazilian Society of Rheumatology followed, use of methotrexate started at the minimum initial dose of 10 mg per week, with reevaluation of treatment being done every four weeks, with the gradual increase in a dose up to a maximum of 25 mg per week in case of partial response [4].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Clinicamente, a febre Chikungunya, apresenta-se na fase aguda pacientes sintomáticos geralmente com inicio abrupto da doença caracterizada por caracterizada por febre alta, poliartralgia, dores nas costas, dor de cabeça e fadiga. Na fase tardia as principais queixas são: dores severas nas articulações dos tornozelos, punhos, cotovelos e ombros, ou seja, artralgia ou dores músculo-esqueléticas com sinais mais longos, perdurando por semanas ou meses, e às vezes por anos (KOHLER et al,2018;MARQUES et al, 2017& RIBEIRO et al, 2016.Outros parâmetros como a gravidade da dor articular e a presença de edemas nas articulações se correlacionam com a cronicidade dos sintomas (SALES et al 2018).…”
Section: Categoria 1: Comprometimento Articularunclassified